Professor Sheng Xu is one of five Stanford winners of the 2026 Guggenheim Fellowship, alongside economics professor Ran ...

Oral agent in second-line more than doubled median PFS in patients with ESR1 muta ...

The use of wearable technology has led to increased demand in the healthcare industry. While covid-19 acted as a trigger for ...

Real-world data presented at HRS 2026 add to the body of evidence supporting a shift away from short-duration Holter monitoring toward up to 14 ...

Researchers combined electronic sensors with human islet cells to create living ‘cyborg’ organoids transmitting troves of ...

Ziftomenib was approved by the U.S. Food and Drug Administration (FDA) in November 2025 for the treatment of adult patients with R/R NPM1 -m AML who have no satisfactory alternative treatment options, ...

Stand with science," researchers at MBZUAI in Abu Dhabi are demonstrating what that means in practice. The race to detect ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that taletrectinib (IBTROZI®) has been added to the latest ...

Nuvation Bio Inc. , a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced results from a pooled analysis of long-term follow-up data from ...

FDA approves vepdegestrant for ER-positive, HER2-negative breast cancer. Learn key efficacy data, safety risks, and nursing ...

The biological connection between a pregnant woman and her developing baby—the human maternal–fetal interface—is a specialized, transient organ composed of uterine cells from the mother and fetal ...

Artificial intelligence is making waves in pediatric and congenital heart care, from earlier diagnosis to personalized treatment and lifelong monitoring. By enhancing imaging, risk prediction, and ...